Basilea Pharmaceutica Profile

USD 0.72  0.91%

Basilea Pharmaceutica Summary

Basilea Pharmaceutica AG (BPMUF) is traded on OTC Market in USA. It is located in Basel, and employs 250 people. The company currently falls under 'Small-Cap' category with current market capitalization of 962.65 M. Basilea Pharmaceutica AG has 10.83 M outstanding shares. BASILEA PHARMACEU has accumulated about 209.88 M in cash with (59.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.38.
Check Basilea Pharmaceutica Probability Of Bankruptcy

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Blair William CoCommon Shares134.4 K15.9 M
View Basilea Pharmaceutica Diagnostics

Basilea Pharmaceutica AG Risk Profiles

Key Fundamentals

Basilea Pharmaceutica Against Markets

Current Ratings

Basilea Pharmaceutica 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 32% 
Equity ratings for Basilea Pharmaceutica AG are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Basilea Pharmaceutica Ltd., together with its subsidiaries, operates as an integrated biopharmaceutical company. more
NameBasilea Pharmaceutica AG
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
Business AddressBasel,
ExchangeOTC Market
Contact Number41 61 606 11 11
CurrencyUSD - US Dollar


Basilea Pharmaceutica Corporate Directors
Thomas Rinderknecht Member of the Board of Directors, Ph.D
Daniel Lew Member of the Board of Directors
Domenico Scala Member of the Board of Directors


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas